Randomized trial of a pharmacist-delivered intervention for improving lipid-lowering medication adherence among patients with coronary heart disease

Cholesterol

Volumn 2010, Issue , 2010, Pages

  Ma, Yunsheng ^a   Ockene, Ira S ^a   Rosal, Milagros C ^a   Merriam, Philip A ^a   Ockene, Judith K ^a   Gandhi, Pritesh J ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COLESEVELAM; COLESTYRAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENOFIBRATE; FLUINDOSTATIN; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEART CATHETERIZATION; HUMAN; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PARENT COUNSELING; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHARMACIST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TELEMEDICINE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79955107353     PISSN: 20901283     EISSN: 20901291     Source Type: Journal    
DOI: 10.1155/2010/383281     Document Type: Article

References (31)

1. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., Haase N., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C. J., Roger V., Rumsfeld J., Sorlie P., Steinberger J., Thom T., Wasserthiel-Smoller S., Hong Y., Heart disease and stroke statistics2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 2007 115 5 e69 e171
2. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 2002 106 25 3143 3421
3. Collins R., Armitage J., Parish S., Sleight P., Peto R., MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial The Lancet 2002 360 9326 7 22 (Pubitemid 34756487)
4. Grundy S. M., Cleeman J. I., Bairey Merz C. N., Brewer H. B. Jr., Clark L. T., Hunninghake D. B., Pasternak R. C., Smith S. C. Jr., Stone N. J., Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 2004 110 2 227 239 (Pubitemid 38924592)
5. Pedersen T. R., Kjekshus J., Berg K., Haghfelt T., Faergeman O., Faergeman G., Pyrl K., Miettinen T., Wilhelmsen L., Olsson A. G., Wedel H., Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994 Atherosclerosis. Supplements 2004 5 3 81 87
6. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group, Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels The New England Journal of Medicine 1998 339 19 1349 1357
7. Sacks F. M., Pfeffer M. A., Moye L. A., Rouleau J. L., Rutherford J. D., Cole T. G., Brown L., Warnica J. W., Arnold J. M.O., Wun C.-C., Davis B. R., Braunwald E., The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels The New England Journal of Medicine 1996 335 14 1001 1009 (Pubitemid 26338729)
8. Cleeman J. I., Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) Journal of the American Medical Association 2001 285 19 2486 2497 (Pubitemid 32433843)
9. Sackett P., Snow J., Haynes R., Taylor D., Sackett D. E., The magnitude of compliance and noncompliance Compliance in Health Care 1979 Baltimore, MD, USA Johns Hopkins Press
10. Sackett D., Haynes R., Compliance with Therapeutic Regimens 1976 Baltimore, MD, USA Johns Hopkins Press
11. Rogers P. G., Bullman W. R., Prescription medicine compliance: a review of the baseline of knowledgea report of the National Council on Patient Information and Education Journal of Pharmacoepidemiology 1996 3 2 3 36 (Pubitemid 26092883)
12. Benner J. S., Glynn R. J., Mogun H., Neumann P. J., Weinstein M. C., Avorn J., Long-term persistence in use of statin therapy in elderly patients Journal of the American Medical Association 2002 288 4 455 461 (Pubitemid 34787476)
13. Berg J. S., Dischler J., Wagner D. J., Raia J. J., Palmer-Shevlin N., Medication compliance: a healthcare problem The Annals of Pharmacotherapy 1993 27 9, supplement S1 S24
14. Andrade S. E., Walker A. M., Gottlieb L. K., Hollenberg N. K., Testa M. A., Saperia G. M., Platt R., Discontinuation of antihyperlipidemic drugsdo rates reported in clinical trials reflect rates in primary care settings? The New England Journal of Medicine 1995 332 17 1125 1131
15. Avorn J., Monette J., Lacour A., Bohn R. L., Monane M., Mogun H., LeLorier J., Persistence of use of lipid-lowering medications: a cross-national study Journal of the American Medical Association 1998 279 18 1458 1462 (Pubitemid 28228203)
16. Simons L. A., Levis G., Simons J., Apparent discontinuation rates in patients prescribed lipid-lowering drugs Medical Journal of Australia 1996 164 4 208 211 (Pubitemid 26057169)
17. Mann D., Reynolds K., Smith D., Muntner P., Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines Annals of Pharmacotherapy 2008 42 9 1208 1215
18. Lachaine J., Rinfret S., Merikle E. P., Tarride J.-E., Persistence and adherence to cholesterol lowering agents: evidence from Rgie de l'Assurance Maladie du Qubec data American Heart Journal 2006 152 1 164 169 (Pubitemid 43974723)
19. Ma Y., Li W., Olendzki B. C., Pagoto S. L., Merriam P. A., Chiriboga D. E., Griffith J. A., Bodenlos J., Wang Y., Ockene I. S., Dietary quality 1 year after diagnosis of coronary heart disease Journal of the American Dietetic Association 2008 108 2 240 246
20. Ockene J. K., Wheeler E. V., Adams A., Hurley T. G., Hebert J., Provider training for patient-centered alcohol counseling in a primary care setting Archives of Internal Medicine 1997 157 20 2334 2341 (Pubitemid 27479332)
21. Rosal M. C., Ebbeling C. B., Lofgren I., Ockene J. K., Ockene I. S., Hebert J. R., Facilitating dietary change: the patient-centered counseling model Journal of the American Dietetic Association 2001 101 3 332 341
22. Steiner J. F., Prochazka A. V., The assessment of refill compliance using pharmacy records: methods, validity, and applications Journal of Clinical Epidemiology 1997 50 1 105 116 (Pubitemid 27089212)
23. Frid D., Ockene I. S., Ockene J. K., Merriam P., Goldberg R., Kristeller J., Barrett S., Severity of angiographically proven coronary artery disease predicts smoking cessation American Journal of Preventive Medicine 1991 7 3 131 135
24. Ockene J., Kristeller J. L., Goldberg R., Ockene I., Merriam P., Barrett S., Pekow P., Hosmer D., Gianelly R., Smoking cessation and severity of disease: the coronary artery smoking intervention study Health Psychology 1992 11 2 119 126
25. Sueta C. A., Chowdhury M., Boccuzzi S. J., Smith S. C. Jr., Alexander C. M., Londhe A., Lulla A., Simpson R. J. Jr., Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease American Journal of Cardiology 1999 83 9 1303 1307 (Pubitemid 29205736)
26. Cohen M. V., Byrne M.-J., Levine B., Gutowski T., Adelson R., Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease Circulation 1991 83 4 1294 1304
27. Miller M., Byington R., Hunninghake D., Pitt B., Furberg C. D., Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada Archives of Internal Medicine 2000 160 3 343 347 (Pubitemid 30075216)
28. Erickson S. R., Slaughter R., Halapy H., Pharmacists' ability to influence outcomes of hypertension therapy Pharmacotherapy 1997 17 1 140 147 (Pubitemid 27057128)
29. Borenstein J. E., Graber G., Saltiel E., Wallace J., Ryu S., Jackson A., Deutsch S., Weingarten S. R., Physician-pharmacist comanagement of hypertension: a randomized, comparative trial Pharmacotherapy 2003 23 2 209 216 (Pubitemid 36204018)
30. Lee J. K., Grace K. A., Taylor A. J., Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial Journal of the American Medical Association 2006 296 21 2563 2571 (Pubitemid 44903860)
31. Grundy S. M., Balady G. J., Criqui M. H., Fletcher G., Greenland P., Hiratzka L. F., Houston-Miller N., Kris-Etherton P., Krumholz H. M., LaRosa J., Ockene I. S., Pearson T. A., Reed J., Smith S. C. Jr., Washington R., When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association task force on risk reduction Circulation 1997 95 6 1683 1685 (Pubitemid 27142848)